Relevance weighting of tier 1 endocrine screening endpoints by rank order

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 101, Issue 1, 2014, Pages 90-113

  Borgert, Christopher J ^a   Stuchal, Leah D ^b   Mihaich, Ellen M ^c   Becker, Richard A ^d   Bentley, Karin S ^e   Brausch, John M ^f   Coady, Katie ^g   Geter, David R ^h   Gordon, Elliot ⁱ   Guiney, Patrick D ^j   Hess, Frederick ^f   Holmes, Catherine M ^f   Lebaron, Matthew J ^g   Levine, Steve ^k   Marty, Sue ^g   Mukhi, Sandeep ^l   Neal, Barbara H ^m   Ortego, Lisa S ^h   Saltmiras, David A ^k   Snajdr, Suzanne ^e   Staveley, Jane ^m   Tobia, Abraham ⁿ   more..

^a Applied Pharmacology and Toxicology Inc   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Environmental and Regulatory Resources   (United States)

^d American Chemistry Council   (United States)

^e DUPONT COMPANY   (United States)

^f BASF CORPORATION   (United States)

^g DOW CHEMICAL COMPANY   (United States)

^h BAYER CROPSCIENCE   (United States)

ⁱ Elliot Gordon Consulting LLC   (United States)

^j S C Johnson & Son Inc   (United States)

^k MONSANTO COMPANY   (United States)

^l FMC Agricultural Products   (United States)

^m EXPONENT INC   (United States)

ⁿ CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

more..

Author keywords

Endocrine disrupters; Endocrine disruptor screening program; Endocrine screening; Regulatory toxicology; Weight of evidence

Indexed keywords

ANDROGEN; ENDOCRINE DISRUPTOR; ESTROGEN; STEROID;

AGONISTS; ANIMAL; BIOASSAY; BIOLOGICAL MODEL; BIOSYNTHESIS; DRUG EFFECTS; METABOLISM; PROCEDURES; RAT; SIGNAL TRANSDUCTION; THYROID GLAND; TOXICITY; TOXICITY TESTING;

ANDROGENS; ANIMALS; ENDOCRINE DISRUPTORS; ENDPOINT DETERMINATION; ESTROGENS; MODELS, BIOLOGICAL; RATS; SIGNAL TRANSDUCTION; STEROIDS; THYROID GLAND; TOXICITY TESTS;

EID: 84894286859     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.21096     Document Type: Article

References (137)

1. Aluru N, Vijayan MM. 2009. Stress transcriptomics in fish: a role for genomic cortisol signaling. Gen Comp Endocrinol 164:142-150.
2. American Heritage® Medical Dictionary Copyright©. 2007 by Houghton Mifflin Company. Published by Houghton Mifflin Company, Boston, MA.
3. Anderson MJ, Miller MR, Hinton DE. 1996a. In vitro modulation of 17-α-estradiol-induced vitellogenin synthesis: effects of cytochrome P4501A1inducing compounds on rainbow trout (Oncorhynchus mykiss) liver cells. Aquat Toxicol 34:327-350.
4. Anderson MJ, Olsen H, Matsumura F, Hinton DE. 1996b. In vivo modulation of17α-estradiol-induced vitellogenin synthesis and estrogen receptor in rainbow trout (Oncorhynchus mykiss) liver cells by β-naphthoflavone. Toxicol Appl. Pharmacol 137:210-218.
5. Ankley GT, Gray LE. 2013. Cross-species conservation of endocrine pathways: A critical analysis of tier 1 fish and rat screening assays with 12 model chemicals. Environ Toxicol Chem. 32(5):1084-1087.
6. Ankley GT, Villeneuve DL. 2006. The fathead minnow in aquatic toxicology: past, present and future. Aquat Toxicol 78:91-102.
7. Ankley G, Mihaich E, Stahl R, Tilitt D, Colborn T, McMaster S, Miller R, Bantle J, Campbell P, Denslow N. 1998. Overview of a workshop on screening methods for detecting potential (anti-) estrogenic/androgenic chemicals in wildlife. Environ Toxicol Chem 17: 68-87.
8. Ankley GT, Jensen KM, Kahl MD, Korte JJ, Makynen EA. 2001. Description and evaluation of a short-term reproduction test with the fathead minnow (Pimephales promelas). Environ Toxicol Chem 20:1276-1290.
9. Ankley GT, Jensen KM, Makynen EA, Kahl MD, Korte JJ, Hornung MW, Henry TR, Denny JS, Leino RL, Wilson VS, Cardon MC, Hartig PC, Gray LE. 2003. Effects of the androgenic growth promoter 17-β-trenbolone on fecundity and reproductive endocrinology of the fathead minnow. Environ Toxicol Chem 22:1350-1360.
10. Ankley GT, Jensen KM, Kahl MD, Makynen EA, Blake LS, Greene KJ, Johnson RD, Villeneuve DL. 2007. Ketoconazole in the fathead minnow (Pimephales promelas): reproductive toxicity and biological compensation. Environ Toxicol Chem 26:1214-1223.
11. Ashby J, Lefevre PA. 2000. The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens and metabolic modulators. J Appl Toxicol 20:35-47.
12. Armada-Dias L, Carvalho J, Breitenbach M, Franci C, Ooura E. 2001. Is the fertility in hypothyroidism mainly due to ovarian or pituitary functional changes? Braz J Med Biol Res 34:1209-1215.
13. Armstrong EJ, Federman DD. 2005. Pharmacology of reproduction, chapter 27. Principles of pharmacology: the pathophysiologic basis of drug therapy. In: Golan DE, editor. Philadelphia, PA: Lippincott Williams & Wilkins.
14. Ashby J, Owens W, Deghenghi R, Odum J. 2002. Concept evaluation: an assay for receptor-mediated and biochemical antiestrogens using pubertal rats. Regul Toxicol Pharmacol 35:393-397.
15. Baker ME. 2002. Beyond carrier proteins albumin, steroid hormones and the origin of vertebrates. J Endocrinol 175:121-127.
16. Battelle. 2005. Final detailed review paper on aromatase. EPA Contract 01-023.
17. Beri R, Kumar N, Savage T, Benalcazar L, Sundaram K. 1998. Estrogenic and progestational activity of 7alpha-methyl-19-nortestosterone, a synthetic androgen. J Steroid Biochem Mol Biol 67:275-283.
18. Black LJ, Jones CD, Goode RL. 1981. Differential interaction of antiestrogens with cytosol estrogen receptors. Mol Cell Endocrinol 22:95-103.
19. Borgert CJ, Mihaich EM, Ortego LS, Bentley KS, Holmes CM, Levine SL, Becker RA. 2011a. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program. Regul Toxicol Pharmacol 61:185-191.
20. Borgert CJ, Mihaich EM, Quill TF, Marty MS, Levine SL, Becker RA. 2011b. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results. Regul Toxicol Pharmacol. 59:397-411.
21. Borgert CJ, Sargent EV, Casella G, Dietrich DR, McCarty LS, Golden RJ. 2012. The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. Regul Toxicol Pharmacol 62:313-328.
22. Borgert CJ, Baker SP, Matthews JC. 2013. Potency matters: thresholds govern endocrine activity. Regul Toxicol Pharmacol 67:83-88.
23. Bovee TFH, Pikkemaat MG. 2009. Bioactivity-based screening of antibiotics and hormones. J Chromatogr A 1216:8035-8050.
24. Brent GA. 2012. Mechanisms of thyroid hormone action. J Clin Invest 122:3035-3043.
25. Bugel SM, White LA, Cooper KR. 2013. Inhibition of vitellogenin gene induction by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin is mediated by aryl hydrocarbon receptor 2 (AHR2) in zebrafish (Danio rerio). Aquat Toxicol 126:1-8.
26. Bulger WH, Kupfer D. 1985. Estrogenic activity of pesticides and other xenobiotics on the uterus and male reproductive tract. Endocrine toxicology. Dixon, RL., Thomas, JA, Korach, KS, McLachlan JA., Eds. New York: Raven Press.
27. Caldwell DJ, Mastrocco F, Anderson PD, Länge R, Sumpter JP. 2012. Predicted-no-effect concentrations for the steroid estrogens estrone, 17β-estradiol, estriol, and 17α-ethinylestradiol. Environ Toxicol Chem 31:1396-1406.
28. Celander MC. 2011. Cocktail effects on biomarker responses in fish. Aquat Toxicol 105S:72-77.
29. Chapin RE, Gulati DK, Barnes LH, Teague JL. 1993. The effects of feed restriction on reproductive function in Sprague-Dawley. Fundam Appl Toxicol 20, 23-29.
30. Clark AS, Kelton MC, Whitney AC. 2003. Chronic administration of anabolic steroids disrupts pubertal onset and estrous cyclicity in rats. Biol Reprod 68:465-471.
31. Clearwater SJ, Pankhurst NW. 1997. The response to capture and confinement stress of plasma cortisol, plasma sex steroids and vitellogenic oocytes in the marine teleost, red gurnard. J Fish Biol 50:429-441.
32. Coady K, Marino T, Thomas J, Currie RJ, Hancock G, Crofoot J, McNalley L, McFadden L, Geter D, Klecka G. 2010. Evaluation of the amphibian metamorphosis assay: exposure to the goitrogen methimazole and the endogenous thyroid hormone L-thyroxine. Environ Toxicol Chem 29:869-880.
33. Cooke, PS, Kirby, JD, Porcelli, J. 1993. Increased testis growth and sperm production in adult rats following transient neonatal goitrogen treatment: optimization of the propylthiouracil dose and effects of methimazole. J Reprod Fertil 97(2):493-499.
34. Cooke PS, Zhao YD, Hansen LG. 1996. Neonatal polychlorinated biphenyl treatment increases adult testis size and sperm production in the rat. Toxicol Appl Pharmacol 136(1):112-117.
35. Degitz SJ, Holcombe GW, Flynn KM, Kosian PA, Korte JJ, Tietge JE. 2005. Progress towards development of an amphibian-based thyroid screening assay using Xenopus laevis. Organismal and thyroidal responses to the model compounds 6-propylthiouracil, methimazole, and thyroxine. Toxicol Sci 87:353-364.
36. Endocrine Policy Forum (EPF). 2013. Available at: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2013-0230-0020. Accessed October 25, 2013.
37. Foo JTW, Lam TJ. 1993. Retardation of ovarian growth and depression of serum steroid levels in the tilapia, Oreochromis mossambicus, by cortisol implantation. Aquaculture 115:133-143.
38. Fritsch MK, Murdoch FE. 1998. Estrogens, progestins, and contraceptives. Chapter 38. Human pharmacology: molecular to clinical. In: Brody TM, editor. St. Louis, MO: Mosby-Year Book, Inc.
39. Galton VA. 1992. The role of thyroid hormone in amphibian metamorphosis. Trends Endocrinol Metab 3:96-100.
40. Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ. 2000. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Crit Rev Toxicol 30:135-196.
41. Gori GB. 2010. Regulating unknown risk. Regulation 33:16-21.
42. Gracia T, Hilscherova K, Jones PD, Newsted JL, Higley EB, Zhang X, Hecker M, Murphy MB, Yu RM, Lam PK, Rudolf RS, Giesy JP. 2007. Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compounds. Toxicol Appl Pharmacol 225:142-153.
43. Gray LE, Wilson V, Noriega N, Furr J, Stoker TE, Laws SC, Goldman J, Cooper RL, Foster PMD. 2004. Use of the laboratory rat as a model in endocrine disruptor screening and testing. ILAR J 45:425-437.
44. Grim KC, Wolfe M, Braunbeck T, Iguchi T, Ohta Y, Tooi O, Touart L, Wolfe DC, Tietge J. 2009. Thyroid histopathology assessments for the amphibian metamorphosis assay to detect thyroid-active substances. Toxicol Pathol 37:415-424.
45. Guyton Arthur C., John E. Hall. 1996a. Female physiology before pregnancy; and the female hormones. Textbook of Medical Physiology. 9th ed. Philadelphia: W.B. Saunders, 1003-1016. 1017-1032.
46. Guyton Arthur C., John E. Hall. 1996b. Reproductive and Hormonal Functions of the Male (and the Pineal Gland). Textbook of Medical Physiology. 9th ed. Philadelphia: W.B. Saunders, 1003-1016.
47. Haddy JA, Pankhurst NW. 1999. Stress-induced changes in concentrations of plasma sex steroids in black bream. J Fish Biol 55:1304-1316.
48. Hagino N. 1976. Effect of thyroid hormone on initiation of persistent oestrus in the rat. Acta Biol Acad Sci Hung 27:93-99.
49. Hammond GL. 2011. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod 85:431-441.
50. Hapon MB, Gamarra-Luques C, Jahn GA. 2010. Short term hypothyroidism affects ovarian function in the cycling rat. Reprod Biol Endocrinol 8:14.
51. Hatsuta M, Abe K, Tamura K, Ryuno T, Watanabe G, Taya K, Kogo H. 2004. Effects of hypothyroidism on the estrous cycle and reproductive hormones in mature female rat. Eur J Pharmacol 486:343-348.
52. Hecker M, Newsted JL, Murphy MB, Higley EB, Jones PD, Wu R, Giesy JP. 2006. Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. Toxicol Appl Pharmacol 217:114-124.
53. Hecker M, Hollert H, Cooper R, Vinggaard AM, Akahori Y, Murphy M, Nellemann C, Higley E, Newstad J, Laskey J, Buckalew A, Grund S, Maletz S, Giesy J, Timm G. 2011. The OECD validation program of the H295R steroidogenesis assay: phase 3. Final inter-laboratory validation study. Environ Sci Pollut Res Int 18:503-515.
54. Hiipakka RA, Liao S. 1995. Androgenic and anabolic steroids and antagonists. Chapter 50. In Principles of pharmacology basic concepts & clinical applications. Munson, PL., Mueller, RA, Breese, GR, Eds. New York, NY: Chapman and Hall.
55. Hilscherova K, Jones PD, Gracia T, Newsted JL, Zhang X, Sanderson JT, Yu RM, Wu RS, Giesy JP. 2004. Assessment of the effects of chemicals on the expression of ten steroidogenic genes in the H295R cell line using real-time PCR. Toxicol Sci 81:78-89.
56. Holson RR, Gough B, Sullivan P, Badger T, Sheehan DM. 1995. Prenatal dexamethasone or stress but not ACTH or corticosterone alter sexual behavior in male rats. Neurotoxicol Teratol 17:393-401.
57. Hutchinson TH, Ankley GT, Segner H, Tyler CR. 2006. Screening and testing for endocrine disruption in fish-biomarkers as ''signposts, '' not ''traffic lights, '' in risk assessment. Environ Health Perspect 114:106-114.
58. Jahnke GD, Choksi NY, Moore JA, Shelby MD. 2004. Thyroid toxicants: assessing reproductive health effects. Environ Health Perspect 112:363-368.
59. Jennings DH, Hanken J. 1998. Mechanistic basis of life history evolution in anuran amphibians: thyroid gland development in the direct-developing frog, Eleutherodactylus coqui. Gen Comp Endocrinol 111:225-232.
60. Jensen KM, Kahl MD, Makynen EA, Korte JJ, Leino RL, Butterworth BC, Ankley GT. 2004. Characterization of responses to the antiandrogen flutamide in a short-term reproduction assay with the fathead minnow. Aquat Toxicol 70:99-110.
61. Juberg DR, Gehen SC, Coady KK, Lebaron MJ, Kramer VJ, Lu H, Marty MS. 2013. Chlorpyrifos: weight of evidence evaluation of potential interaction with the estrogen, androgen, or thyroid pathways. Regul Toxicol Pharmacol 66:249-263.
62. Kanno J, Onyon L, Haseman J, Fenner-Crisp P, Ashby J, Owens W. 2001. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ Health Perspect 109(8):785-794.
63. Kanno J, Onyon L, Peddada S, Ashby J, Jacob E, Owens W. 2003. The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies. Environ Health Perspect 111(12):1550-1558.
64. Kicman AT. 2010. Biochemical and physiological aspects of endogenous androgens. Handb Exp Pharmacol 195:25-64
65. Kim HS, Shin JH, Moon HJ, Kim TS, Kang IH, Seok JH, Kim IY, Park KL, Han SY. 2002. Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide. Toxicol Sci 67:52-62.
66. Korach KS, Migliaccio S, Davis VL. 1995. Estrogens. In: Munson, PL., Mueller, RA, Breese, GR, Eds. Principles of Pharmacology: Basic Concepts & Clinical Applications. New York: Chapman & Hall 809-825.
67. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.
68. Lanzino M, Maris P, Sirianni R, Barone I, Casaburi I, Chimento A, Giordano C, Morelli C, Sisci D, Rizza P, Bonofiglio D, Catalano S, Ando S. 2013. DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation. Cell Death Dis 4:e724.
69. Laws SC, Yavanhxay S, Copper RL, Eldridge JC. 2006. Nature of the binding interaction for 50 structurally diverse chemicals with rat estrogen receptors. Toxicol Sci 94(1):46-56.
70. Laws SC, Stoker TE, Ferrell JM, Hotchkiss MG, Cooper RL. 2007. Effects of altered food intake during pubertal development in male and female wistar rats. Toxicol Sci 100:194-202.
71. Lethimonier C, Flouriot G, Valotaire Y, Kah O, Ducouret B. 2000. Transcriptional interference between gluccocorticoid receptor and estradiol receptor mediates the inhibitory effect of cortisol on fish vitellogenesis. Biol Reprod 62:1763-1771.
72. Li Y, Kumazawa T, Ishiguro T, Kawakami Y, Nishitani H, Tagawa Y, Matsumoto Y. 2011. Hypothyroidism caused by phenobarbital affects patterns of estrous cyclicity in rats. Congenit Anom (Kyoto) 51:55-61.
73. Lubzens E, Young G, Bobe J, Cerdà J. 2010. Oogenesis in teleosts: how eggs are formed. Gen Comp Endocrinol 165:367-389.
74. Lutz I, Kloas W, Springer TA, Holden LR, Wolf JC, Krueger HO, Hosmer AJ. 2008. Development, standardization and refinement of procedures for evaluating effects of endocrine active compounds on development and sexual differentiation of Xenopus laevis. Anal Bioanal Chem 390:2031-2048.
75. MacGregor JI, Jordan VC. 1998. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50:151-196.
76. Martinović D, Blake LS, Durhan EJ, Greene KJ, Kahl MD, Jensen KM, Makynen EA, Villeneuve DL, Ankley GT. 2008. Reproductive toxicity of vinclozolin in the fathead minnow: confirming an anti-androgenic mode of action. Environ Toxicol Chem 27:478-488.
77. Marty MS. 2013. Mammalian methods for detecting and assessing endocrine-active compounds. Endocrine disruptors. Hazard testing and assessment methods. In: Matthiessen P, editor. Hoboken, NJ: John Wiley & Sons, Inc. p 304-340.
78. Marty MS, Crissman JW, Carney EW. 1999. Evaluation of the EDSTAC female pubertal assay in CD rats using 17beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor. Toxicol Sci 52:269-277.
79. Marty MS, Crissman JW, Carney EW. 2001a. Evaluation of the male pubertal assay's ability to detect thyroid inhibitors and dopaminergic agents. Toxicol Sci 60:63-76.
80. Marty MS, Crissman JW, Carney EW. 2001b. Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats. Toxicol Sci 60:285-295.
81. Marty MS, Johnson KA, Carney EW. 2003. Effect of feed restriction on Hershberger and pubertal male assay endpoints. Birth Defects Res B Dev Reprod Toxicol 68:363-374.
82. Marty MS, Carney EW, Rowlands JC. 2011. Endocrine disruption: historical perspectives and its impact on the future of toxicology testing. Toxicol Sci 120(Suppl 1):S93-S108.
83. McCarty LS, Borgert CJ, Mihaich EM. 2012. Information quality in regulatory decision-making: peer-review versus good laboratory practice. Environ Health Perspect 120:927-934.
84. Milla S, Wang N, Mandiki SNM, Kestemont P. 2009. Corticosteroids: friends or foes of teleost fish reproduction? Comp Biochem Physiol Part A 153:242-251.
85. Miller WL, Auchus RJ. 2011. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81-151
86. Mills LJ, Chichester C. 2008. Review of evidence: are endocrine-disrupting chemicals in the aquatic environment impacting fish populations? Sci Total Environ 343:1-34.
87. Negus SS. 2006. Some implications of receptor theory for in vivo assessment of agonists, antagonists and inverse agonists. Biochem Pharmacol 71:1663-1670.
88. O'Connor JC, Davis LG, Frame SR, Cook JC. 2000. Evaluation of a tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. Toxicol Sci 54:338-354.
89. Odum J, Lefevre PA, Tittensor S, Paton D, Routledge EJ, Beresford NA, Sumpter JP, Ashby J. 1997. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol 25:176-188.
90. Organization for Economic Cooperation and Development (OECD). 2004a. Detailed review paper on fish screening assays for the detection of endocrine active substances. Available at: http://www.oecd-ilibrary.org/docserver/download/9750471e.pdf?expires=1382988166&id=id&accname=guest&checksum=0797CBA2C275400AB5EFB3BE62C5B5F0. Accessed October 28, 2013.
91. Organization for Economic Cooperation and Development (OECD). 2004b. Detailed review paper on amphibian metamorphosis assay for the detection of thyroid active substances. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/edmvac/oecd_amphibian_drp.pdf. Accessed October 28, 2013.
92. Organization for Economic Cooperation and Development (OECD). 2007a. Final report of the validation of the 21-day fish screening assay for the detection of endocrine active substances. Series on testing and assessment number 78. ENV/JM/MONO(2007)25.
93. Organization for Economic Cooperation and Development (OECD). 2007b. OECD guideline for the testing of chemicals. Uterotrophic bioassay in rodents: a short-term screening test for oestrogenic properties. Available at: http://www.oecd-ilibrary.org/docserver/download/9744001e.pdf?expires=1382988559&id=id&accname=guest&checksum=701B965B460ABEA80055190B33E45266. Accessed October 28, 2013.
94. Organization for Economic Cooperation and Development (OECD). 2007c. Validation of the amphibian metamorphosis assay as a screen for thyroid-active chemicals: integrated summary report. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/ama_isr.pdf. Accessed October 28, 2013.
95. Organization for Economic Cooperation and Development (OECD). 2009a. OECD guideline for the testing of chemicals Hershberger bioassay in rats: a short-term screening assay for (anti)androgenic properties. Available at: http://www.oecd-ilibrary.org/docserver/download/9744101e.pdf?expires=1382988624&id=id&accname=guest&checksum=F2F2873C27F2B066BCF29AC1D3179C1A. Accessed October 28, 2013.
96. Organization for Economic Cooperation and Development (OECD). 2009b. OECD guideline for the testing of chemicals 21-day fish assay: a short-term screening for oestrogenic and androgenic activity, and aromatase inhibitions. Available at: http://www.oecd-ilibrary.org/docserver/download/9723001e.pdf?expires=1382988737&id=id&accname=guest&checksum=70DAFD1299CEC50ABB86606FD2102B80. Accessed October 28, 2013.
97. Organization for Economic Cooperation and Development (OECD). 2009c. OECD guideline for the testing of chemicals the amphibian metamorphosis assay. Available at: http://www.oecd-ilibrary.org/docserver/download/9723101e.pdf?expires=1382988799&id=id&accname=guest&checksum=842FFDCB326C1A944186556C5FDA5823. Accessed October 28, 2013.
98. Organization for Economic Cooperation and Development (OECD). 2012. Guidance document on standardised test guidelines for evaluating chemicals for endocrine disruption no 150. Organisation for Economic Cooperation and Development, Paris, 24-Aug-2012. Available at: http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote=ENV/JM/MONO(2012)22&doclanguage=en. Accessed October 28, 2013.
99. Ososki AL, Kennelly EJ. 2003. Phytoestrogens: a review of the present state of research. Phytother Res 17:845-869.
100. Owens W, Ashby J. 2002. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit Rev Toxicol 32(6): 445-520.
101. Owens W, Ashby J, Odum J, Onyon L. 2003. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses. Environ Health Perspect 111(12):1559-1567.
102. Pankhurst NW, Van Der Kraak G. 2000. Evidence that acute stress inhibits ovarian steroidogenesis in rainbow trout in vivo, through action of cortisol. Gen Comp Endocrinol 117:225-237.
103. Parks LG, Cheek AO, Denslow ND, Heppell SA, McLachlan JA, LeBlanc GA, Sullivan CV. 1999. Fathead minnow (Pimephales promelas) vitellogenin: purification, characterization and quantitative immunoassay for the detection of estrogenic compounds. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 123:113-125.
104. Pereyra-Martinez AC, Roselli CE, Stadelman HL, Resko JA. 2001. Cytochrome P450 aromatase in testis and epididymis of male rhesus monkeys. Endocrine 16:15-19.
105. Pickford DB. 2010. Screening chemicals for thyroid-disrupting activity: a critical comparison of mammalian and amphibian models. Crit Rev Toxicol 40:845-892.
106. Quignot N, Desmots S, Barouki R, Lemazurier E. 2012. A comparison of two human cell lines and two rat gonadal cell primary cultures as in vitro screening tools for aromatase modulation. Toxicol In Vitro 26:107-118.
107. Reel JR, Lamb IV JC, Neal BH. 1996. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol 34:288-305.
108. Rocca MS, Pepperl S. 2000. Final report assessment of pubertal development and thyroid function in juvenile male rats. Sponsored by Environmental Protection Agency RTP: MD-71 NHEERL Research Triangle Park, NC 27711. TherImmune Research Corporation, Study Number 1143-100, 15 Firstfield Road, Gaithersburg, MD 20878.
109. Rozman KK, Bhatia J, Calafat AM, Chambers C, Culty M, Etzel RA, Flaws JA, Hansen DK, Hoyer PB, Jeffery EH, Kesner JS, Marty S, Thomas JA and Umbach D. 2006. NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Defects Res B Dev Reprod Toxicol 77:485-638.
110. Schmid T, Gonzalez-Valero J, Rufli H, Dietrich DR. 2002. Determination of vitellogenin kinetics in male fathead minnows (Pimephales promelas). Toxicol Lett 131:65-74.
111. Schmidt WN, Katzenellenbogen BS. 1979. Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis. Mol Cell Endocrinol 15:91-108.
112. Shappell NW, Hyndman KM, Bartell SE, Schoenfuss HL. 2010. Comparative biological effects and potency of 17α- and 17β-estradiol in fathead minnows. Aquat Toxicol 100:1-8.
113. Shayu D, Rao AJ. 2006. Expression of functional aromatase in the epididymis: role of androgens and LH in modulation of expression and activity. Mol Cell Endocrinol 249:40-50.
114. Shin JH, Kim HS, Moon HJ, Kang H, Kim TS, Seok JH, Kim IJ, Park KL, Han SY, Nam SY. 2002. Effects of flutamide on puberty in male rats: an evaluation of the protocol for the assessment of pubertal development and thyroid function. J Toxicol Environ Health A 65:433-445.
115. Stoker T, Zorrilla L. 2010. The effects of endocrine disrupting chemicals on pubertal development in the rat. Endocrine toxicology. 3rd ed. Eldridge, C., Steven, JT., Eds. CRC Press. p 27-81.
116. Stoker TE, Parks LG, Gray LE, Cooper RL. 2000. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee. Crit Rev Toxicol 30:197-252.
117. Stromborg KL. 1986. Reproduction of bobwhites fed different dietary concentrations of an organophosphate insecticide, methamidophos. Arch Environ Contam Toxicol 15:143-147.
118. Tata JR. 2006. Amphibian metamorphosis as a model for the developmental actions of thyroid hormone. Mol Cell Endocrinol 246:10-20.
119. U.S. EPA. 1999. Review of the EPA's proposed environmental disruptor screening program; review of the Endocrine Disruptor Screening Program by a Joint Subcommittee of the Science Advisory Board and Scientific Advisory Panel. EPA-SAB-EC-99-013. Available at: http://yosemite.epa.gov/sab/sabproduct.nsf/C8ABD410E357D-BCF85257193004C42C4/$File/ec13.pdf. Accessed July 18, 2010.
120. U.S. EPA. 2006. Fish screening assay discussion paper.
121. U.S. EPA. 2007a. Endocrine Disruptor Screening Program. Validation of the fish short term reproduction assay: integrated summary report. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/fish_assay_isr.pdf. Accessed October 28, 2013.
122. U.S. EPA. 2007b. Integrated summary report for validation of a test method for assessment of pubertal development and thyroid function in juvenile male rats as a potential screen in the Endocrine Disruptor Screening Program Tier-1 Battery. Office of Science Coordination and Policy and Office of Research and Development. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/male_pubertal_isr.pdf. Accessed October 28, 2013.
123. U.S. EPA. 2007c. Integrated summary report for validation of a test method for assessment of pubertal development and thyroid function in juvenile female rats as a potential screen in the Endocrine Disruptor Screening Program Tier-1 Battery. Office of Science Coordination and Policy and Office of Research and Development. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/female_isr_v4.1c.pdf. Accessed October 28, 2013.
124. U.S. EPA. 2009. Series 890-Endocrine Disruptor Screening Test OPPTS 890.1500: pubertal development and thyroid function in intact juvenile/peripubertal male rats. Available at: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2009-0576-0010. Accessed October 28, 2013.
125. U.S. EPA (Environmental Protection Agency). 2011a. Weight-of-evidence: evaluating results of EDSP Tier 1 screening to identify the need for Tier 2 testing. EPA-HQ-OPPT-2010-0877-0021. Available at: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2010-0877-0021. Accessed October 22, 2013.
126. U.S. EPA (Environmental Protection Agency). 2011b. Endocrine Disruptor Screening Program Test Guidelines. OCSPP 890.1400: Hershberger assay. Standard Evaluation Procedure. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/toresources/seps/Final_890.1600_Hershberger_Assay_SEP_10.6.11.pdf. Accessed October 28, 2013.
127. U.S. EPA (Environmental Protection Agency). 2011c. Endocrine Disruptor Screening Program Test Guidelines. OCSPP 890.1150: androgen receptor binding assay (rat ventral prostate cytosol. Standard Evaluation Procedure. Available at: http://www.epa.gov/scipoly/oscpendo/pubs/toresources/seps/Final_890.1150_AR_Bindng_Assay_SEP_10.5.11.pdf. Accessed October 28, 2013.
128. U.S. National Library of Medicine. 2013. MeSH Headings-NCBI: "Androgen Antagonists" definition. Available at: http://www.ncbi.nlm.nih.gov/mesh/?term=androgenantagonists. Accessed October 28, 2013.
129. Vitale DC, Piazza C, Melilli B, Drago F, Salomone S. 2012. Isoflavones: estrogenic activity, biological effect and bioavailability. Eur J Drug Metab Pharmacokinet 38:15-25.
130. Wade GN, Blaustein JD, Gray JM, Meredith JM. 1993. ICI 182, 780: a pure antiestrogen that affects behaviors and energy balance in rats without acting in the brain. Am J Physiol 265:R1392-R1398.
131. Wang S, Aarts JM, Evers NM, Peijnenburg AA, Rietjens IM, Bovee TF. 2012. Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect. J Steroid Biochem Mol Biol 128:98-106.
132. Wason S, Pohlmeyer-Esch G, Pallen C, Palazzi X, Espuña G, Bars R. 2003. 17α-methyltestosterone: 28-day oral toxicity study in the rat based on the "Enhanced OECD Test Guideline 407" to detect endocrine effects. Toxicology 192:119-137.
133. Wilbur HM, Collins JP. 1973. Ecological aspects of amphibian metamorphosis: nonnormal distributions of competitive ability reflect selection for facultative metamorphosis. Science 182:1305-1314.
134. Winters SJ. 1998. Androgens and antiandrogens chapter 39. Human pharmacology: molecular to clinical. In: Brody TM, editor. St. Louis, MO: Mosby-Year Book, Inc.
135. Wu RSS, Zhou BS, Randall DJ, Woo NTY, Lam PKS. 2003. Aquatic hypoxia is an disrupter and impairs fish reproduction. Environ Sci Technol 37:1137-1141.
136. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
137. York RG, Brown WR, Girard MF, Dollarhide JS. 2001. Two-generation reproduction study of ammonium perchlorate in drinking water in rats evaluates thyroid toxicity. Int J Toxicol 20:183-197.